Reduced Risk, Upcoming Pipeline Inspire Bull Case For Novartis
July 26, 2017 at 15:52 PM EDT
Novartis AG (ADR) (NYSE: NVS) has been all over the news lately as its cancer drug moves closer to FDA approval, and Morgan Stanley ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.